Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Kangpu Biopharmaceuticals Initiates Phase Ib/IIa Clinical Trial of KPG-818 in Systemic Lupus Erythematosus
2020-11-17 09:00
Alterity announces approval of US patent for next generation compounds to treat neurodegenerative diseases
2020-11-17 01:09
Sofwave receives CE Medical Mark and additional key Regulatory Clearances for its Revolutionary Skin Tightening and Wrinkle Reduction Device
2020-11-17 01:00
Princ Suvarnabhumi Hospital Achieves GHA's COVID-19 Certification of Conformance for Medical Travel
2020-11-16 23:04
Covis Group Completes Acquisition of AMAG Pharmaceuticals
2020-11-16 22:43
Viatris Inc. Launches as a New Kind of Healthcare Company, Positioned to Meet the World's Evolving Healthcare Needs
2020-11-16 20:30
Harbour BioMed Will Present Results From Its Phase II Clinical Trial with Tanfanercept (HBM9036) in Patients with Moderate-to-Severe Dry Eye Disease in China at the 25th Congress of Chinese Ophthalmological Society
2020-11-16 20:17
INOVIO Announces Initiation of Phase 2 Segment of its Phase 2/3 Clinical Trial for its COVID-19 DNA Vaccine Candidate, INO-4800; Trial Will Be Funded by the U.S. Department of Defense
2020-11-16 20:00
KPCPEN Introduces Two Paediatric Professors to Accelerate the Preparation of COVID-19 Vaccine
2020-11-16 16:46
Gilead Sciences Announces Recipients of its First Asia HIV Research Scholar Program
2020-11-16 15:02
Cytiva supports Clover Biopharmaceuticals to scale up the output of its vaccine candidate
2020-11-16 14:00
Innovent Announces the Results of the Phase I Clinical Trial of IBI302, a First-in-class Ophthalmic Recombinant Human Anti-VEGF and Anti-Complement Bi-specific Fusion Protein for Neovascular Age-Related Macular Degeneration at 2020 American Academy of Ophthalmology
2020-11-16 08:00
International Diabetes Federation calls for improved funding and training to help nurses tackle the global diabetes crisis
2020-11-14 08:00
The third CIIE concludes, $72.6 billion in intended deals for the coming year inked
2020-11-14 03:21
CHMP Adopted Positive Opinion for ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
2020-11-14 01:03
FDI World Dental Federation: Study shows dramatic rise in antibiotics prescribed to dental patients in England during COVID-19 lockdown earlier this year
2020-11-14 01:00
The fourth CIIE begins taking stall reservations from exhibitors
2020-11-13 21:00
AlpVision to offer free of charge security feature to protect COVID-19 relevant medicines against counterfeiting
2020-11-13 20:25
Positive Results from RhoVac's Clinical Phase I/II Study published in Journal of ImmunoTherapy of Cancer
2020-11-13 17:53
iONEBIO Inc. Deployment of FICS (Fast Infection Control System) at the International Airport of Paraguay
2020-11-13 16:29
1
400
401
402
403
404
740